# ZARS Pharma Inc. clinical trials: 24 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 24 trials with ZARS Pharma Inc. as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by ZARS Pharma Inc.: 24 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/zars-pharma-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 24
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 24 newest of 24, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| May 21, 2012 | NCT01602757 | Pharmacokinetic Study of Synera in Healthy Volunteers | ZARS Pharma Inc. | Phase 1 | Completed | Healthy | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01602757) |
| April 28, 2010 | NCT01111773 | Study Evaluating a Heated Lidocaine and Tetracaine Topical Patch in the Treatment of Patients With Patellar Tendinopathy | ZARS Pharma Inc. | Phase 2 | Completed | Patellar Tendinopathy | 13 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01111773) |
| April 20, 2010 | NCT01106989 | Study Evaluating Heated Lidocaine/Tetracaine Patch in Patients With Pain Associated With Myofascial Trigger Points | ZARS Pharma Inc. | Phase 2 | Completed | Myofascial Pain Syndromes | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01106989) |
| January 25, 2010 | NCT01055444 | Study Evaluating Heated Lidocaine/Tetracaine Topical Patch in Treatment of Patients With Shoulder Impingement Syndrome | ZARS Pharma Inc. | Phase 2 | Completed | Shoulder Impingement Syndrome | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01055444) |
| October 7, 2009 | NCT00991068 | Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel Syndrome | ZARS Pharma Inc. | Phase 2 | Completed | Carpal Tunnel Syndrome | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00991068) |
| May 1, 2009 | NCT00891163 | Evaluate the Depth and Duration of Anesthesia | ZARS Pharma Inc. | Phase 4 | Completed | Pain | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00891163) |
| April 30, 2009 | NCT00890968 | Safety and Efficacy Study of Triamcinolone Acetonide DuraPeel to Treat Hand Dermatitis | ZARS Pharma Inc. | Phase 2 | Completed | Hand Dermatoses | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00890968) |
| September 5, 2008 | NCT00747669 | Pharmacokinetic Study of Synera™ in Neonates and Infants | ZARS Pharma Inc. | Phase 4 | Suspended | Pain | 11 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00747669) |
| February 7, 2008 | NCT00609323 | Lidocaine and Tetracaine Cream to Treat Postherpetic Neuralgia (PHN) | ZARS Pharma Inc. | Phase 2 | Completed | Postherpetic Neuralgia | 23 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00609323) |
| September 19, 2007 | NCT00532038 | A Phase 3 Study to Evaluate the Long-Term Safety of ThermoProfen™ in Patients With Mild to Moderate Pain Associated With Osteoarthritis of... | ZARS Pharma Inc. | Phase 3 | Terminated | Osteoarthritis | 179 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00532038) |
| June 20, 2007 | NCT00488267 | Efficacy of ThermoProfen in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee | ZARS Pharma Inc. | Phase 3 | Completed | Osteoarthritis | 679 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00488267) |
| January 18, 2006 | NCT00278824 | Fentanyl Transdermal Patch With CHADD™ for Breakthrough Pain in Patients With Moderate to Severe Non-Malignant Pain | ZARS Pharma Inc. | Phase 2 | Terminated | Pain | 109 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00278824) |
| August 4, 2005 | NCT00126789 | Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain | ZARS Pharma Inc. | Phase 3 | Terminated | Pain, Cancer | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00126789) |
| August 4, 2005 | NCT00126763 | Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Non-Malignant Pain | ZARS Pharma Inc. | Phase 3 | Terminated | Pain | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00126763) |
| July 29, 2005 | NCT00125255 | S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Vascular Access Procedures in Children | ZARS Pharma Inc. | Phase 3 | Completed | Pain | 81 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00125255) |
| May 13, 2005 | NCT00110773 | S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Pulsed Dye Laser (PDL) Therapy in Adults | ZARS Pharma Inc. | Phase 3 | Completed | Pain | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00110773) |
| May 13, 2005 | NCT00110760 | S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Skin Filler Injection in the Face | ZARS Pharma Inc. | Phase 3 | Completed | Pain | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00110760) |
| May 13, 2005 | NCT00110747 | S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Non-Ablative Facial Laser Resurfacing in Adults | ZARS Pharma Inc. | Phase 3 | Completed | Pain | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00110747) |
| May 13, 2005 | NCT00110734 | S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Laser-Assisted Tattoo Removal in Adults | ZARS Pharma Inc. | Phase 3 | Completed | Pain | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00110734) |
| May 5, 2005 | NCT00110253 | Duration of Skin Numbing Effect Created by the S-Caine™ Peel | ZARS Pharma Inc. | Phase 3 | Completed | Pain | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00110253) |
| April 19, 2005 | NCT00108810 | Transdermal Ketoprofen to Treat Mild to Moderate Osteoarthritis (OA) Pain of the Knee | ZARS Pharma Inc. | Phase 2 | Completed | Pain, Osteoarthritis, Knee | 118 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00108810) |
| April 19, 2005 | NCT00108771 | Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Osteoarthritis (OA) Pain | ZARS Pharma Inc. | Phase 2 | Completed | Pain | 202 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00108771) |
| April 11, 2005 | NCT00107835 | Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Adults | ZARS Pharma Inc. | Phase 3 | Completed | Pain | 408 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00107835) |
| April 11, 2005 | NCT00107822 | Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Children | ZARS Pharma Inc. | Phase 3 | Completed | Pain | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00107822) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 1 |
| Phase 2 | 9 |
| Phase 3 | 12 |
| Phase 4 | 2 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 19 |
| Terminated | 4 |
| Suspended | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Pain | 19 |
| Chronic Pain | 4 |
| Osteoarthritis | 4 |
| Neoplasms | 1 |
| Cancer Pain | 1 |
| Myofascial Pain Syndromes | 1 |
| Neuralgia, Postherpetic | 1 |
| Carpal Tunnel Syndrome | 1 |
| Agnosia | 1 |
| Hand Dermatoses | 1 |
| Shoulder Impingement Syndrome | 1 |
| Osteoarthritis, Knee | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Burger restaurants in the United States](https://specstream.ai/data/businesses/burger-restaurants/united-states)
- [Paralegal companies in the United States](https://specstream.ai/data/businesses/paralegal-companies/united-states)
- [Chicken restaurants in the United States](https://specstream.ai/data/businesses/chicken-restaurants/united-states)
- [Plastic manufacturers in the United States](https://specstream.ai/data/businesses/plastic-manufacturers/united-states)
- [Construction companies in the United States](https://specstream.ai/data/businesses/construction-companies/united-states)
- [Psychiatry practices in the United States](https://specstream.ai/data/businesses/psychiatry-practices/united-states)
